NCT05780762 Impact of an Intervention Integrating the MPHS Nursing Model of Care on the Partnership in Health, With the Patient Followed in Primary Care by an Advanced Practice Nurse (APN) for One or More Stabilized Chronic Pathologies
| NCT ID | NCT05780762 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Condition | Chronic Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 420 participants |
| Start Date | 2024-04-12 |
| Primary Completion | 2028-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 420 participants in total. It began in 2024-04-12 with a primary completion date of 2028-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The WHO and our governance advocate that health professionals should organize care around the patient, considering his or her values, needs and preferences, and enabling the patient to develop the capacity to self-manage the chronic health problems he or she faces. Chronic disease is an ongoing dynamic process and adaptation to this process is complicated by the interaction of several determinants: self-management capacity, level of health literacy, quality of life and experience of care. To best support chronic disease, the recommendation is to adopt a management strategy that allows chronic patients to play an active role in the management of their condition and in the day-to-day decision-making process. The management of chronic pathologies is one of the specialties in which Advanced Practice Nurses are positioned, in primary care, outside hospital. Nursing care benefits from care models that allow for more adapted responses, regarding particular care situations, or certain patient typologies. The Humanistic Partnership Health Care Model (MPHS) implement in current Advanced Practice Nurse (APN) practice.
Eligibility Criteria
Inclusion Criteria: * A patient receiving care from an advanced practice nurse (APN) for the management of one or more of the following chronic conditions: stroke; chronic arterial disease; heart disease, coronary artery disease; type 1 diabetes and type 2 diabetes; chronic respiratory failure; Parkinson's disease; epilepsy. * Care provided by an IPA falls under one of the following categories: Either as direct care when the IPA practices within a healthcare facility, in accordance with current regulations, Or as care referred or prescribed by a physician when the IPA practices in private practice. * Affiliated or entitled to a social security plan * Having received informed information about the study and having co-signed, with the investigator, a consent to participate in the study Exclusion Criteria: \- A patient who is not under the care of a nurse practitioner under the conditions set forth in the Public Health Code (lack of authorized direct access or a required physician referral, depending on the practice model).
Contact & Investigator
Elise VEROT, MD
PRINCIPAL INVESTIGATOR
CHUSE
Frequently Asked Questions
Who can join the NCT05780762 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05780762 currently recruiting?
Yes, NCT05780762 is actively recruiting participants. Contact the research team at elise.verot@univ-st-etienne.fr for enrollment information.
Where is the NCT05780762 trial being conducted?
This trial is being conducted at Firminy, France, Saint-Chamond, France, Saint-Etienne, France, Saint-Etienne, France and 1 additional location.
Who is sponsoring the NCT05780762 clinical trial?
NCT05780762 is sponsored by Centre Hospitalier Universitaire de Saint Etienne. The principal investigator is Elise VEROT, MD at CHUSE. The trial plans to enroll 420 participants.